# Alafair Biosciences, Inc.

> Alafair Biosciences is an Austin, Texas commercial-stage medical device company that makes bioresorbable, plant-based hydrogel implants to protect healing soft tissue after surgery. Built on its patented VersaCore hydrogel technology - a collagen-free, dye-free blend of naturally derived hyaluronic acid and alginate - the company's VersaWrap Hydrogel Sheet and VersaCoat Flowable Hydrogel create a non-constricting gliding interface around tendons, ligaments and peripheral nerves to limit postoperative tethering and help patients regain function. More than 40,000 VersaWrap implants have been used across orthopedic, spine, hand and plastic/reconstructive procedures.

- **Founded:** 2011
- **Headquarters:** Austin, Texas, United States
- **Founders:** John Joyoprayitno (President & CEO, Co-Founder), Sarah Mayes, PhD (Chief Scientific Officer & Co-Founder)
- **Team size:** ~61 employees
- **Products:** VersaWrap Hydrogel Sheet, VersaCoat Flowable Hydrogel, VersaWrap Application Kit, VersaCore Hydrogel Technology
- **Notable:** 40,000+ VersaWrap implants used in patients across multiple specialties, 722% year-over-year growth reported in 2025, Named to the Inc. 5000 list three consecutive years

## Products & services

- **VersaWrap Hydrogel Sheet** — A conformable, sutureless, bioresorbable hydrogel sheet that wraps injured or exposed tendons and peripheral nerves, forming a semi-permeable, hyaluronic-acid-rich gliding interface that limits tethering during healing. 510(k) cleared (K200311).
- **VersaCoat Flowable Hydrogel** — A syringe-deliverable flowable version of the VersaCore hydrogel for precise placement in tight anatomy and minimally invasive procedures; forms a conformable, tissue-adherent, non-constricting gliding interface between tissue planes.
- **VersaWrap Application Kit** — A procedural kit that supports consistent preparation and delivery of the VersaWrap Hydrogel Sheet in the operating room.
- **VersaCore Hydrogel Technology** — The underlying platform combining naturally derived, high-molecular-weight hyaluronic acid and alginate in a collagen-free, dye-free, fully bioresorbable formulation.

## Achievements

- 40,000+ VersaWrap implants used in patients across multiple specialties
- 722% year-over-year growth reported in 2025
- Named to the Inc. 5000 list three consecutive years
- CEO/Co-Founder John Joyoprayitno named to Inc.'s Business Leader of the Year list (Dec 2025)
- Named to Inc.'s 2025 Best in Business list
- Recognized as a 2026 Inc. Best Workplace
- Portfolio of 30 issued and 5 pending patents
- FDA 510(k) clearance for VersaWrap (K200311)
- Launched VersaCoat, described as the first flowable gel for soft-tissue protection (2026)

## Latest updates

- **2026-06** — Launched VersaCoat Flowable Hydrogel, a syringe-deliverable version of its VersaCore technology for minimally invasive and complex anatomy.
- **2025-12** — CEO John Joyoprayitno named to Inc.'s Business Leader of the Year list; company named to Inc.'s Best in Business list, reporting 722% year-over-year growth and 35,000+ VersaWrap implants.
- **2025-03** — Reported strong 2024 growth and continued expansion of its distribution network.
- **2024-01** — Announced 12,000+ VersaWrap implants in patients milestone.

## Links

- Website: https://alafairbiosciences.com
- LinkedIn: https://www.linkedin.com/company/alafairbiosciences
- Twitter/X: https://x.com/AlafairBio
- YouTube: https://www.youtube.com/channel/UCWzK7vVliy_RelzS8WIwALw
- Bluesky: https://bsky.app/profile/alafairbiosciences.bsky.social

---

Profile page: https://yespress.io/alafair-biosciences-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-22